2
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Prostatic Neoplasms
11
Lung Neoplasms
7
Colonic Neoplasms
5
Pancreatic Neoplasms
3
Pain, Postoperative
3
Inflammatory Bowel Diseases
3
Diverticulitis
3
Carcinoma, Hepatocellular
3
Urinary Bladder Neoplasms
2
Male Urogenital Diseases
2
Leiomyoma
2
Inflammation
2
Carcinoma, Non-Small-Cell Lung
2
Agnosia
2
Abdominal Cancer
2
Unspecified Adult Solid Tumor, Protocol Specific
1
Thyroid Neoplasms
1
Stomatitis
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Smoking Cessation
1
Skin Neoplasms
1
Shoulder Pain
1
Respiration Disorders
1
Psychological Well-Being
1
Postoperative Complications
1
Post-thoracotomy Pain Syndrome
1
Pleural Diseases
1
Neoplasms
1
Mouth Neoplasms
1
Interventions
Cisplatin
281
pembrolizumab
234
Radiotherapy
171
Cetuximab
169
Carboplatin
123
Docetaxel
110
Paclitaxel
96
Fluorouracil
95
Nivolumab
88
Radiotherapy, Intensity-Modulated
80
Magnetic Resonance Spectroscopy
39
durvalumab
36
Radiation
33
Surgical Procedures, Operative
32
Drug Therapy
32
Biopsy
28
Radiosurgery
25
Erlotinib Hydrochloride
25
Albumin-Bound Paclitaxel
24
130-nm albumin-bound paclitaxel
24
Taxes
23
Specimen Handling
22
Platinum
22
Immunohistochemistry
21
tislelizumab
20
1,2-diaminocyclohexaneplatinum II citrate
20
Cyclophosphamide
19
Chemoradiotherapy
19
Capecitabine
19
tremelimumab
18
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Squamous Cell Carcinoma of Head and Neck
×
Tea
×
Clear all
NCT06875791
2025-04-01
TEMOR
Fundacion Clinica Valle del Lili
Phase 1/2
Not yet recruiting
40 enrolled